Nephros (NEPH) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.22% |
| Dec 31, 2025 | -8.12% |
| Sep 30, 2025 | 0.06% |
| Jun 30, 2025 | -6.36% |
| Mar 31, 2025 | -14.56% |
| Dec 31, 2024 | -2.03% |
| Sep 30, 2024 | -8.61% |
| Jun 30, 2024 | -6.53% |
| Mar 31, 2024 | 0.14% |
| Dec 31, 2023 | -1.23% |
| Sep 30, 2023 | -2.78% |
| Jun 30, 2023 | 3.11% |
| Mar 31, 2023 | 16.09% |
| Dec 31, 2022 | 10.62% |
| Sep 30, 2022 | 92.26% |
| Jun 30, 2022 | 69.24% |
| Mar 31, 2022 | 46.51% |
| Dec 31, 2021 | 90.91% |
| Sep 30, 2021 | 55.55% |
| Jun 30, 2021 | 38.88% |
| Mar 31, 2021 | 63.39% |
| Dec 31, 2020 | 45.89% |
| Sep 30, 2020 | 23.24% |
| Jun 30, 2020 | 46.70% |
| Mar 31, 2020 | 89.47% |
| Dec 31, 2019 | 26.54% |
| Dec 31, 2018 | 51.24% |
| Mar 31, 2018 | 49.57% |
| Dec 31, 2017 | 115.69% |
| Sep 30, 2017 | -16.34% |
| Jun 30, 2017 | -21.14% |
| Mar 31, 2017 | -18.06% |
| Dec 31, 2016 | -30.28% |
| Sep 30, 2016 | -17.54% |
| Jun 30, 2016 | -1.33% |
| Mar 31, 2016 | -20.78% |
| Dec 31, 2015 | 39.06% |
| Sep 30, 2015 | 33.91% |
| Jun 30, 2015 | 24.69% |